Invention Grant
- Patent Title: Antibody molecules to dengue virus and uses thereof
-
Application No.: US16173678Application Date: 2018-10-29
-
Publication No.: US11059883B2Publication Date: 2021-07-13
- Inventor: Luke Robinson , Zachary Shriver , James R. Myette , Gregory Babcock , Karthik Viswanathan
- Applicant: VISTERRA, INC.
- Applicant Address: US MA Waltham
- Assignee: VISTERRA, INC.
- Current Assignee: VISTERRA, INC.
- Current Assignee Address: US MA Waltham
- Agency: Lando & Anastasi, LLP
- Main IPC: C07K16/10
- IPC: C07K16/10 ; A61K39/42 ; G01N33/569 ; A61K45/06 ; A61K39/00
Abstract:
Antibody molecules that specifically bind to dengue virus are disclosed. In certain embodiments, the antibody molecule bind to dengue virus serotypes DV-1, DV-2, DV-3, and DV-4. The antibody molecules can be used to treat, prevent, and/or diagnose dengue virus.
Public/Granted literature
- US20190153074A1 ANTIBODY MOLECULES TO DENGUE VIRUS AND USES THEREOF Public/Granted day:2019-05-23
Information query
